These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23110471)

  • 21. 24-hour efficacy and safety of Triple-Combination Therapy With Olmesartan, Amlodipine, and Hydrochlorothiazide: the TRINITY ambulatory blood pressure substudy.
    Izzo JL; Chrysant SG; Kereiakes DJ; Littlejohn Iii T; Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
    J Clin Hypertens (Greenwich); 2011 Dec; 13(12):873-80. PubMed ID: 22142346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of amlodipine/olmesartan medoxomil ± hydrochlorothiazide in patients aged ≥ 65 or < 65 years with uncontrolled hypertension on prior monotherapy.
    Weir MR; Shojaee A; Maa JF
    Postgrad Med; 2013 Mar; 125(2):124-34. PubMed ID: 23816778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of olmesartan medoxomil and hydrochlorothiazide fixed-dose combination therapy in patients aged 65 years and older with stage 1 and 2 hypertension or isolated systolic hypertension.
    Germino FW; Neutel JM; Dubiel R; Maa JF; Chavanu KJ
    Am J Cardiovasc Drugs; 2012 Oct; 12(5):325-33. PubMed ID: 22920048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide.
    Chrysant SG; Weber MA; Wang AC; Hinman DJ
    Am J Hypertens; 2004 Mar; 17(3):252-9. PubMed ID: 15001200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of high dose olmesartan medoxomil plus hydrochlorothiazide on blood pressure control in patients with grade 2 and grade 3 hypertension.
    Rump LC; Girerd X; Sellin L; Stegbauer J
    J Hum Hypertens; 2011 Sep; 25(9):565-74. PubMed ID: 21107435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olmesartan medoxomil/amlodipine/hydrochlorothiazide: fixed-dose combination in hypertension.
    Deeks ED
    Drugs; 2011 Jan; 71(2):209-20. PubMed ID: 21275446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of an amlodipine/olmesartan treatment algorithm in patients with or without type 2 diabetes and hypertension (a secondary analysis of the BP-CRUSH study).
    Nesbitt SD; Shojaee A; Maa JF; Weir MR
    J Hum Hypertens; 2013 Jul; 27(7):445-52. PubMed ID: 23254596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of a stepped-care regimen using olmesartan medoxomil, amlodipine and hydrochlorothiazide in patients with moderate-to-severe hypertension: an open-label, long-term study.
    Volpe M; Miele C; Haag U
    Clin Drug Investig; 2009; 29(6):381-91. PubMed ID: 19432498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of long-term treatment with the combination of amlodipine besylate and olmesartan medoxomil in patients with hypertension.
    Chrysant SG; Oparil S; Melino M; Karki S; Lee J; Heyrman R
    J Clin Hypertens (Greenwich); 2009 Sep; 11(9):475-82. PubMed ID: 19751459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.
    Oparil S; Chrysant SG; Melino M; Lee J; Karki S; Heyrman R
    J Hum Hypertens; 2010 Dec; 24(12):831-8. PubMed ID: 20200547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and tolerability of an olmesartan medoxomil-based regimen in patients with stage 1 hypertension: a randomized, double-blind, placebo-controlled study.
    Chrysant SG
    Clin Drug Investig; 2010; 30(7):473-82. PubMed ID: 20528002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients.
    Destro M; Crikelair N; Yen J; Glazer R
    Vasc Health Risk Manag; 2010 Sep; 6():821-7. PubMed ID: 20859551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of the fixed-dose combination of olmesartan/amlodipine/hydrochlorothiazide for the treatment of hypertension in patients stratified by age, race and diabetes, CKD and chronic CVD.
    Chrysant SG
    Expert Rev Cardiovasc Ther; 2013 Sep; 11(9):1115-24. PubMed ID: 24073676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy/safety of a fixed-dose amlodipine/olmesartan medoxomil-based treatment regimen in hypertensive blacks and non-blacks with uncontrolled BP on prior antihypertensive monotherapy.
    Nesbitt S; Shojaee A; Maa JF
    J Clin Hypertens (Greenwich); 2013 Apr; 15(4):247-53. PubMed ID: 23551724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.
    Calhoun DA; Lacourcière Y; Chiang YT; Glazer RD
    Hypertension; 2009 Jul; 54(1):32-9. PubMed ID: 19470877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of an olmesartan medoxomil based treatment algorithm on 24-hour blood pressure control in patients with hypertension and type 2 diabetes.
    Neutel JM; Kereiakes DJ; Waverczak WF; Stoakes KA; Xu J; Shojaee A
    Curr Med Res Opin; 2010 Mar; 26(3):721-8. PubMed ID: 20085534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension.
    Oparil S; Barr E; Elkins M; Liss C; Vrecenak A; Edelman J
    Clin Ther; 1996; 18(4):608-25. PubMed ID: 8879890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Essential Hypertension (RESOLVE): A Large, Observational, Retrospective, Cohort Study.
    Park SJ; Rhee SJ
    Adv Ther; 2020 Aug; 37(8):3500-3514. PubMed ID: 32557349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subgroup analyses of an efficacy and safety study of concomitant administration of amlodipine besylate and olmesartan medoxomil: evaluation by baseline hypertension stage and prior antihypertensive medication use.
    Oparil S; Lee J; Karki S; Melino M
    J Cardiovasc Pharmacol; 2009 Nov; 54(5):427-36. PubMed ID: 19730391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.